Skip to main content
Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · IEX Real-Time Price · USD
18.63
+0.03 (0.16%)
At close: Apr 24, 2024, 4:00 PM
19.35
+0.72 (3.86%)
After-hours: Apr 24, 2024, 7:58 PM EDT

Myriad Genetics Market Cap

Myriad Genetics has a market cap or net worth of $1.67 billion as of April 24, 2024. Its market cap has decreased by -7.48% in one year.

Market Cap
1.67B
Enterprise Value
1.69B
1-Year Change
-7.48%
Ranking
#2054
Category
Small-Cap
Stock Price
$18.63

Market Cap Chart

Since December 1, 1998, Myriad Genetics's market cap has increased from $102.30M to $1.67B, an increase of 1,536.72%. That is a compound annual growth rate of 11.63%.

History

DateMarket Cap% Change
Apr 23, 20241.67B0.60%
Apr 22, 20241.66B-0.05%
Apr 19, 20241.66B-0.05%
Apr 18, 20241.66B-0.70%
Apr 17, 20241.68B-1.48%
Apr 16, 20241.70B-1.31%
Apr 15, 20241.72B-1.95%
Apr 12, 20241.76B-4.63%
Apr 11, 20241.84B1.18%
Apr 10, 20241.82B-2.97%
Apr 9, 20241.88B2.65%
Apr 8, 20241.83B0.40%
Apr 5, 20241.82B0.20%
Apr 4, 20241.82B-0.39%
Apr 3, 20241.82B1.50%
Apr 2, 20241.80B-6.72%
Apr 1, 20241.93B0.56%
Mar 28, 20241.92B-0.37%
Mar 27, 20241.92B-0.42%
Mar 26, 20241.93B-2.23%
Mar 25, 20241.98B-1.17%
Mar 22, 20242.00B-0.27%
Mar 21, 20242.00B0.27%
Mar 20, 20242.00B2.96%
Mar 19, 20241.94B-0.14%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
NeoGenomics 1.73B
Structure Therapeutics 1.69B
Sana Biotechnology 1.68B
Amneal Pharmaceuticals 1.67B
Harmony Biosciences Holdings 1.67B
Agios Pharmaceuticals 1.64B
Inhibrx 1.63B
Neumora Therapeutics 1.62B
Market Cap Rankings